Le Lézard
Classified in: Health
Subject: LAW

Attorney Sandra Neuman, of Sandra Neuman Law, secured a $1.4 million verdict against UPMC Passavant


Sandra Neuman Law secured a $1.4 million medical malpractice verdict against UPMC Passavant for negligence resulting from a fall that caused permanent injury to his dominant arm.

PITTSBURGH, March 1, 2024 /PRNewswire-PRWeb/ -- On Thursday, February 29, an Allegheny County jury awarded a 62-year-old man from Mars, PA, $1.4 million in damages for negligence resulting from a fall that caused permanent injury to his dominant arm. The incident occurred when the man was admitted to UPMC Passavant for a scheduled hip surgery. His surgery had to be postponed due to low sodium levels. During this time, he was identified as a level 2 fall risk requiring bathroom supervision. He was escorted to the bathroom by two UPMC employees but then left alone. The fall caused a severe fracture to his dominant arm requiring extensive medical interventions, including three surgeries thus far with a looming fourth surgery, a fusion.

It's an amazing feeling to be able to help my client, and quite frankly, all victims of medical negligence who have been dismissed by the health system that is supposed to protect them.

Defense Counsel Fredrick Bode and Alyssa Dedola from Dickie McCamey & Chilcote represented UPMC Passavant.

Counsel for plaintiff was astonished by UPMC's decision to contest liability during the trial, given the evidence amassed during pre-trial discovery and depositions. Attorney Sandra Neuman, representing the plaintiff, uncovered internal UPMC documents highlighting critical lapses in care. These documents revealed that despite being designated as high-risk for falls, the patient was left unattended, contrary to established protocols.

However, during the trial, a key care provider, a patient care technician, altered his testimony, asserting that the plaintiff had not been left alone?a stark contradiction to the documented evidence.

Neuman expressed her dismay at UPMC's attempt to shift blame onto her client, who had been previously characterized by UPMC caretakers as impulsive and lacking safety awareness due to his medical condition. She emphasized the importance of holding medical institutions accountable for negligence, stating, "It's an amazing feeling to be able to help my client, and quite frankly, all victims of medical negligence who have been dismissed by the health system that is supposed to protect them."

Despite the jury finding the client 17% liable for his injuries, they awarded him $1.4 million. Attorney Drew Rummel, who assisted Neuman with the trial, added "We were fortunate enough to have a great jury that saw the truth and awarded our client the justice he deserved."

Case No. GD-22-1441 MICHAEL A. ROTZ vs.UPMC PASSAVANT

Media Contact

Sandra Neuman, Sandra Neuman Law, 1 4123680367, [email protected]https://mymedmalattorneys.com/

SOURCE Sandra Neuman Law


These press releases may also interest you

at 02:05
Genflow...

at 02:00
Leading scientists, philanthropists, and policymakers from around the world are coming together in Denmark at the Global Science Summit, hosted by the Novo Nordisk Foundation as part of the organisation's 100-year anniversary. The goal is to explore...

at 01:00
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement clears path for launch of Jubbonti® and Wyost® on...

at 00:30
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology...

at 00:00
The Riverside Company, a global private investor focused on the smaller end of the middle market, has closed the acquisition of Arbeidsmiljø og Energiteknikk AS (AET), a Norwegian distributor of third-party consumables and laboratory / cleaning...

at 00:00
COEUS Solutions, a leading provider of innovative technologies and services in the life sciences industry, today announces its rebranding to BridgeView Life Sciences ("BridgeView") following a recent spinoff from its former parent company. This marks...



News published on and distributed by: